PHARMACOGENETIC ASSOCIATION OF beta 1-ADRENERGIC RECEPTOR SER49GLY POLYMORPHISM WITH OUTCOMES IN THE SECONDARY PREVENTION OF SMALL SUBCORTICAL STROKES (SPS3) TRIAL.
CLINICAL PHARMACOLOGY & THERAPEUTICS(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要